Chief Executive Officer for the CDC Foundation Joins CDC Deputy Director for Infectious Diseases to Speak at Everbridge COVID-19: Road to Recovery (R2R) Executive Summit, May 26-27, 2021
Dr. Judy Monroe, CDC Foundation Chief Executive Officer, and Dr. Jay C. Butler, CDC Deputy Director for Infectious Diseases (DDID), Join 42nd United States President Bill Clinton, Publishing Icon Steve Forbes, former United States Secretary of State Dr. Madeleine K. Albright, and C-Level Business and Healthcare Leaders to Discuss Very Latest Updates on Coronavirus Pandemic and Vaccine Distribution
BURLINGTON, Mass., May 4, 2021 — Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced that Dr. Judy Monroe, CDC Foundation President and Chief Executive Officer, and Dr. Jay C. Butler, CDC Deputy Director for Infectious Diseases (DDID), will present at its Spring 2021 COVID-19: Road to Recovery (R2R) virtual leadership summit taking place May 26-27. These two leaders in philanthropy and infectious disease will cover the current state of the pandemic, the coronavirus vaccine rollout and what to expect in the latest phase of the global crisis as life and business begin to recover.
The two-day symposium will feature keynote addresses from 42nd President of the United States Bill Clinton, Chairman & Editor-In-Chief of Forbes Media, Steve Forbes, and United States Secretary of State (1997-2001) Madeleine K. Albright, and include presentations from world leaders, health experts and C-suite executives from cross-industry and geography.
“We remain grateful to the work of both the Centers for Disease Control and Prevention and the CDC Foundation, and to the important insights Dr. Monroe and Dr. Butler will share related to the latest phase of the pandemic,” said David Meredith, Chief Executive Officer, Everbridge. “We look forward to bringing together the world’s experts to exchange best practices on how to more safely reintegrate people back to public spaces, reopen economies, and protect employees and citizens from future outbreaks.”
“Today, we are at a critical point in the pandemic response,” said Dr. Monroe. “Global cases are tragically spiking in some parts of the world, including India, while in the United States we have seen significant progress to reduce COVID cases based on greater numbers of those vaccinated. While this progress is promising, there is much work left to do both in the United States and across the globe. We are pleased that Everbridge is keeping these issues at the forefront, and we appreciate their support of vital response efforts.”
Everbridge Symposium Healthcare Panels:
The Everbridge symposium will feature a broad range of healthcare-related panels, including the following speakers:
- Dr. Judy Monroe, CDC Foundation President and Chief Executive Officer
- Dr. Jay C. Butler, CDC Deputy Director for Infectious Diseases (DDID)
- Roberta Schwartz, Ph.D., FACHE, Executive Vice President & Chief Innovation Officer, Houston Methodist Hospital
- Sarah Matthew, Founder & CEO, The Vibrant Company & Chair, Hanover Health
- Bonnie Michelman, Executive Director of Police, Security & Outside Services, MGH
- Diego Rodriguez, VP of Security, New York Presbyterian
- Fran Lawler, Chief Human Resources Officer, athenahealth
The life-saving work of the CDC Foundation, an independent nonprofit, remains paramount to helping the Centers for Disease Control and Prevention Crush COVID by forging partnerships between CDC and others to fight threats to health and safety. All contributions to the Crush COVID campaign support community-based organizations to increase COVID-19 vaccine uptake in high-need communities, build vaccine confidence, and ensure equitable and accessible vaccine administration. To learn how to support the CDC Foundation COVID-19 response, please visit https://give4cdcf.org/everbridge21
Last year, Everbridge welcomed President George W. Bush, Anthony Fauci, MD, Scott Gottlieb, MD, Sanjay Gupta, MD, U.S. General Colin L. Powell, USA (Ret.), and Virgin Group Founder Sir Richard Branson, among others, to serve as keynote speakers. The events attracted more than 40,000 participants including government officials, healthcare experts and senior executives from 150 countries, as well as participants from the Centers for Disease Control and Prevention, the Mayo Clinic, Goldman Sachs, Fannie Mae, Ford Motor Company, Humana, IBM, and others.
To register for the Everbridge Spring 2021 COVID-19 R2R: The Road to Recovery Symposium, click here.
Everbridge, Inc. (NASDAQ: EVBG) is a global software company that provides enterprise software applications that automate and accelerate organizations’ operational response to critical events in order to Keep People Safe and Organizations Running™. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events including IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 5,600 global customers rely on the Company’s Critical Event Management Platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes through the secure delivery to over 100 different communication modalities, and track progress on executing response plans. Everbridge serves 8 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, 47 of the 50 busiest North American airports, 9 of the 10 largest global consulting firms, 8 of the 10 largest global automakers, 9 of the 10 largest U.S.-based health care providers, and 7 of the 10 largest technology companies in the world. Everbridge is based in Boston with additional offices in 20 cities around the globe. For more information visit www.everbridge.com
Cautionary Language Concerning Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the anticipated opportunity and trends for growth in our critical communications and enterprise safety applications and our overall business, our market opportunity, our expectations regarding sales of our products, our goal to maintain market leadership and extend the markets in which we compete for customers, and anticipated impact on financial results. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the ability of our products and services to perform as intended and meet our customers’ expectations; our ability to successfully integrate businesses and assets that we may acquire; our ability to attract new customers and retain and increase sales to existing customers; our ability to increase sales of our Mass Notification application and/or ability to increase sales of our other applications; developments in the market for targeted and contextually relevant critical communications or the associated regulatory environment; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate; we have not been profitable on a consistent basis historically and may not achieve or maintain profitability in the future; the lengthy and unpredictable sales cycles for new customers; nature of our business exposes us to inherent liability risks; our ability to attract, integrate and retain qualified personnel; our ability to maintain successful relationships with our channel partners and technology partners; our ability to manage our growth effectively; our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.